Search Results - Russell Pachynski

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Radiation and Checkpoint Inhibitor Immunotherapy Lead to Long Term Disease Control in a Metastatic RCC patient With Brain Metastases by Maria Levitin, Joel Ofori, Woo Jae Shin, Jiayi Huang, Mackenzie Daly, Dengfeng Cao, Russell Pachynski, Russell Pachynski

    Published in Frontiers in Oncology (2020-09-01)
    Get full text
    Article


  2. 2

    1109 Chemerin suppresses prostate tumor growth by modulating the recruitment of effector NK and CD8+ T-cells into the tumor microenvironment by Bo Peng, Russell Pachynski, Kevin Kim, Muhammad A Saeed

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  3. 3

    #8. Radium-223 treated primary patient bone biopsy analysis: Macro to microscale analyses and dosimetry by Nadia Benabdallah, Peng Lu, Jeff Michalski, Brian Baumann, Russell Pachynski, Jack Jennings, Robert F. Hobbs, Daniel L.J. Thorek

    Published in Journal of Bone Oncology (2024-04-01)
    Get full text
    Article


  4. 4

    423 A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer by Lawrence Fong, Russell Pachynski, Peter Oppelt, Melissa Reimers, Cody Weimholt, Katie Slane, Jason Frankel, Robert Figenshau, Eric Kim, Gerald Andriole

    Published in Journal for ImmunoTherapy of Cancer (2021-11-01)
    Article


  5. 5

    377 IL-15 treatment enhances the in vivo anti-tumor efficacy of sipuleucel-T by activating CD8+ T and NKT effector cells, augmenting tumor infiltration, and reversing immunoresista... by Bo Peng, Tuyen Vu, Nadeem Sheikh, Russell Pachynski, Brian Van Tine, Todd Fehniger, Kevin Kim, Muhammad A Saeed, Ariel Borkowski, Daniel Thorek

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  6. 6

    285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors by Marcus Butler, David Hong, Ryan Sullivan, Matthew Frigault, Sarah Boross-Harmer, Ecaterina Dumbrava, Jean-Marc Navenot, Svetlana Fayngerts, Jane Bai, Elliot Norry, Paula Fracasso, Russell Pachynski, Partow Kebriaei, Amy Sauer, Francine Brophy

    Published in Journal for ImmunoTherapy of Cancer (2020-11-01)
    Article


  7. 7

    759 ADPORT-601 (TT-10–101): first-in-human study of adenosine 2A (A2A) and adenosine 2B (A2B) receptor antagonists in participants with selected advanced solid tumors by Lawrence Fong, Sumit Subudhi, Gerald S Falchook, Russell Pachynski, Anthony El-Khoueiry, Ian Walters, Robert Krämer, Sushant Kumar, Kasim Mookhtiar, Justin Fairchild, Mohamad A Salkeni, Jaspreet Grewal, William Tester, Samik Upadhaya, Ana Rosa Saez Ibanez, Desa Rae Stanton-Pastore

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  8. 8

    665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress by Neal Shore, Robert Dreicer, Matthew Zibelman, Mark N Stein, Ralph J Hauke, Russell Pachynski, Bethan Jones, Jessica Hawley, Charlotte Davis, Katie Anderson, Antonella Vardeu, Margaret A Marshall, Vicky Wheeler, Sarah Sebastian, Kevin Kayvan Zarrabi, Brian Miles, Jennifer Bendall

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


Search Tools: